These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 27839814)

  • 21. Differences in the extent of fibrosis in obstructive and nonobstructive hypertrophic cardiomyopathy.
    Avegliano G; Politi MT; Costabel JP; Kuschnir P; Trivi M; Ronderos R
    J Cardiovasc Med (Hagerstown); 2019 Jun; 20(6):389-396. PubMed ID: 30994509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue Doppler imaging during exercise stress echocardiography demonstrates a mechanism for impaired exercise performance in children with hypertrophic cardiomyopathy.
    Ferguson ME; Sachdeva R; Gillespie SE; Morrow G; Border W
    Echocardiography; 2016 Nov; 33(11):1718-1725. PubMed ID: 27545012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PET/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy.
    Bravo PE; Pinheiro A; Higuchi T; Rischpler C; Merrill J; Santaularia-Tomas M; Abraham MR; Wahl RL; Abraham TP; Bengel FM
    J Nucl Med; 2012 Mar; 53(3):407-14. PubMed ID: 22315440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated left ventricular outflow tract velocities on exercise stress echocardiography may be a normal physiologic response in healthy youth.
    Wittlieb-Weber CA; Cohen MS; McBride MG; Paridon SM; Morrow R; Wasserman M; Wang Y; Stephens P
    J Am Soc Echocardiogr; 2013 Dec; 26(12):1372-8. PubMed ID: 24139056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left ventricular diastolic function assessed with cardiovascular magnetic resonance imaging and exercise capacity in patients with non-obstructive hypertrophic cardiomyopathy.
    Małek LA; Chojnowska L; Kłopotowski M; Misko J; Dabrowski M; Kuśmierczyk-Droszcz B; Maczyńska R; Piotrowicz E; Ruzyłło W
    Kardiol Pol; 2009 Jan; 67(1):1-6; discussion 7-8. PubMed ID: 19253184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relation between left ventricular outflow tract obstruction and left ventricular shape in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study.
    Martin R; Lairez O; Boudou N; Méjean S; Lhermusier T; Dumonteil N; Berry M; Cognet T; Massabuau P; Elbaz M; Rousseau H; Galinier M; Carrié D
    Arch Cardiovasc Dis; 2013; 106(8-9):440-7. PubMed ID: 23906680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction.
    Maron MS; Olivotto I; Zenovich AG; Link MS; Pandian NG; Kuvin JT; Nistri S; Cecchi F; Udelson JE; Maron BJ
    Circulation; 2006 Nov; 114(21):2232-9. PubMed ID: 17088454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
    Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of resting and exercise echocardiographic parameters as indicators of outcomes in hypertrophic cardiomyopathy.
    Reant P; Reynaud A; Pillois X; Dijos M; Arsac F; Touche C; Landelle M; Rooryck C; Roudaut R; Lafitte S
    J Am Soc Echocardiogr; 2015 Feb; 28(2):194-203. PubMed ID: 25459499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional difference of microcirculation in patients with asymmetric hypertrophic cardiomyopathy: transthoracic Doppler coronary flow velocity reserve analysis.
    Tesic M; Djordjevic-Dikic A; Beleslin B; Trifunovic D; Giga V; Marinkovic J; Petrovic O; Petrovic M; Stepanovic J; Dobric M; Vukcevic V; Stankovic G; Seferovic P; Ostojic M; Vujisic-Tesic B
    J Am Soc Echocardiogr; 2013 Jul; 26(7):775-82. PubMed ID: 23643850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormal longitudinal myocardial functional reserve assessed by exercise tissue Doppler echocardiography in patients with hypertrophic cardiomyopathy.
    Ha JW; Ahn JA; Kim JM; Choi EY; Kang SM; Rim SJ; Jang Y; Shim WH; Cho SY; Oh JK; Chung N
    J Am Soc Echocardiogr; 2006 Nov; 19(11):1314-9. PubMed ID: 17098132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Latent obstruction and left atrial size are predictors of clinical deterioration leading to septal reduction in hypertrophic cardiomyopathy.
    Finocchiaro G; Haddad F; Pavlovic A; Sinagra G; Schnittger I; Knowles JW; Perez M; Magavern E; Myers J; Ashley E
    J Card Fail; 2014 Apr; 20(4):236-43. PubMed ID: 24486928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Left ventricular function at rest and during exercise and the effects of propranolol in patients with hypertrophic cardiomyopathy].
    Amano K; Sakamoto T; Sugimoto T
    J Cardiol Suppl; 1987; 16():35-51. PubMed ID: 3509682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expanding the indications for septal myectomy in patients with hypertrophic cardiomyopathy: results of operation in patients with latent obstruction.
    Schaff HV; Dearani JA; Ommen SR; Sorajja P; Nishimura RA
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):303-9. PubMed ID: 22154797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Exercise echocardiography in the evaluation of obstructive types of hypertrophic cardiomyopathy].
    Shao CL; Duan FJ; Qiao SB; You SJ; Hu FH; Yuan JS
    Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):484-8. PubMed ID: 24059995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue Doppler imaging in hypertrophic cardiomyopathy: impact of intraventricular obstruction on longitudinal left ventricular function.
    Cardim N; Torres D; Morais H; Cândido A; Duarte R; Longo S; Ferreira T; Pereira A; Gouveia A; Reis RP; Correia JM
    Rev Port Cardiol; 2002 Mar; 21(3):271-97. PubMed ID: 12017801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiopulmonary responses and prognosis in hypertrophic cardiomyopathy: a potential role for comprehensive noninvasive hemodynamic assessment.
    Finocchiaro G; Haddad F; Knowles JW; Caleshu C; Pavlovic A; Homburger J; Shmargad Y; Sinagra G; Magavern E; Wong M; Perez M; Schnittger I; Myers J; Froelicher V; Ashley EA
    JACC Heart Fail; 2015 May; 3(5):408-418. PubMed ID: 25863972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of exercise limitation in hypertrophic cardiomyopathy.
    Chikamori T; Counihan PJ; Doi YL; Takata J; Stewart JT; Frenneaux MP; McKenna WJ
    J Am Coll Cardiol; 1992 Mar; 19(3):507-12. PubMed ID: 1538001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography.
    Patel P; Dhillon A; Popovic ZB; Smedira NG; Rizzo J; Thamilarasan M; Agler D; Lytle BW; Lever HM; Desai MY
    Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003132. PubMed ID: 26082555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term effects of dual chamber pacing in patients with hypertrophic cardiomyopathy without outflow tract obstruction at rest.
    Gadler F; Linde C; Juhlin-Dannfelt A; Ribeiro A; Rydén L
    Eur Heart J; 1997 Apr; 18(4):636-42. PubMed ID: 9129895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.